John P. Neis's most recent trade in Cellectar Biosciences Inc was a trade of 25,000 Stock option (right to buy) done . Disclosure was reported to the exchange on July 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cellectar Biosciences Inc | John P. Neis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2026 | 25,000 | 25,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | John P. Neis | Director | Sale of securities on an exchange or to another person at price $ 3.70 per share. | 12 Dec 2025 | 198 | 10 (0%) | 0% | 3.7 | 732 | Common Stock |
| Cellectar Biosciences Inc | John P. Neis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | John P. Neis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | John P. Neis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 25,000 | 47,887 | - | - | Stock option (right to buy) | |
| Cellectar Biosciences Inc | John P. Neis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 7,800 | 7,800 | - | - | Stock option (right to buy) |